Skip to content

Praxis Precision Medicines

US · PRAX #1645 by market cap Listed 2020
300.43 -10.47 -3.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Company notice
    Adways: Adways has begun operating "PRAX," an AI solution that leverages its accumulated expertise in promotional proposal services.
    JPX · 2026/11/5
  • Rating change
    Raymond James Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $945
    Market Newswire · 2026/8/17
  • Rating change
    Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $650
    Market Newswire · 2026/8/18
  • Rating change
    JonesTrading Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $534
    Market Newswire · 2026/10/2
  • Rating change
    Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $582
    Market Newswire · 2026/9/24
  • Rating change
    Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $575
    Market Newswire · 2026/8/21
  • Rating change
    J.P. Morgan Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $700
    Market Newswire · 2026/10/16
  • Rating change
    LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $754
    Market Newswire · 2026/8/8
  • Praxis Precision Medicines (PRAX.US) will release its financial report before the market opens on November 9.
    Market Newswire · 2026/11/4
  • Rating change
    BTIG Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $826
    Market Newswire · 2026/10/6
  • A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $343 to $1,201
    Market Newswire · 2026/11/11
  • Rating change
    BTIG Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $826
    Market Newswire · 2026/11/3
  • RBC Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $478
    Market Newswire · 2026/11/14
  • Rating change
    Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $575
    Market Newswire · 2026/8/20
  • Rating change
    UBS Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $706
    Market Newswire · 2026/10/15
  • Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,200
    Market Newswire · 2026/11/13
  • Company notice
    Praxis Precision Medicines: Praxis Precision Medicines, Inc. - Reverse Split Option Symbol: PRAX New Symbol: PRAX1
    OCC · 2023/11/28
  • H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,201
    Market Newswire · 2026/11/13
  • Rating change
    UBS Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $706
    Market Newswire · 2026/10/15
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Prime Medicine, Inc. (PRME)
    TipRanks · 2026/10/6
  • Rating change
    A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $462 to $800
    Market Newswire · 2026/8/7
  • Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,200
    Market Newswire · 2026/10/22
  • Rating change
    A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $441 to $1,201
    Market Newswire · 2026/8/8
  • H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,201
    Market Newswire · 2026/10/15
  • Rating change
    LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $719
    Market Newswire · 2026/7/22

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:15 · For reference only, not investment advice and not tailored to your situation.

Praxis Precision Medicines discussion 0 comments

Add a comment